| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Clinical Trials as Topic | 12 | 2020 | 848 | 2.420 |
Why?
|
| Health Status Disparities | 9 | 2018 | 326 | 2.200 |
Why?
|
| Colorectal Neoplasms | 12 | 2019 | 561 | 2.130 |
Why?
|
| Neoplasms | 13 | 2020 | 1667 | 2.120 |
Why?
|
| Patient Selection | 12 | 2021 | 592 | 1.950 |
Why?
|
| Minority Groups | 11 | 2022 | 197 | 1.790 |
Why?
|
| Breast Neoplasms | 10 | 2020 | 1536 | 1.700 |
Why?
|
| Cancer Survivors | 4 | 2020 | 146 | 1.680 |
Why?
|
| Population Surveillance | 3 | 2019 | 285 | 1.530 |
Why?
|
| Biomedical Research | 5 | 2021 | 310 | 1.400 |
Why?
|
| Patient Compliance | 6 | 2019 | 402 | 1.370 |
Why?
|
| Health Services Research | 8 | 2015 | 209 | 1.320 |
Why?
|
| Healthcare Disparities | 8 | 2020 | 378 | 1.290 |
Why?
|
| Health Knowledge, Attitudes, Practice | 8 | 2020 | 767 | 1.240 |
Why?
|
| Patient Participation | 4 | 2020 | 146 | 1.230 |
Why?
|
| Prostatic Neoplasms | 10 | 2014 | 778 | 1.220 |
Why?
|
| Community Networks | 4 | 2017 | 96 | 1.180 |
Why?
|
| Mass Screening | 9 | 2012 | 843 | 1.120 |
Why?
|
| Health Education | 4 | 2020 | 279 | 1.090 |
Why?
|
| Early Detection of Cancer | 3 | 2020 | 454 | 1.080 |
Why?
|
| Obesity | 3 | 2018 | 1076 | 1.050 |
Why?
|
| Uterine Cervical Neoplasms | 3 | 2020 | 300 | 1.010 |
Why?
|
| Social Support | 9 | 2014 | 423 | 1.010 |
Why?
|
| Patient Navigation | 3 | 2020 | 30 | 0.980 |
Why?
|
| Humans | 93 | 2022 | 68618 | 0.930 |
Why?
|
| Attitude to Health | 7 | 2017 | 403 | 0.860 |
Why?
|
| Insurance Coverage | 3 | 2020 | 99 | 0.850 |
Why?
|
| Patient Acceptance of Health Care | 6 | 2019 | 468 | 0.850 |
Why?
|
| Exercise | 2 | 2020 | 658 | 0.840 |
Why?
|
| Female | 57 | 2022 | 38074 | 0.830 |
Why?
|
| Aged | 41 | 2021 | 14862 | 0.830 |
Why?
|
| South Carolina | 16 | 2019 | 2752 | 0.800 |
Why?
|
| Lung Neoplasms | 8 | 2020 | 1173 | 0.780 |
Why?
|
| Middle Aged | 45 | 2021 | 21147 | 0.780 |
Why?
|
| Physicians | 5 | 2022 | 324 | 0.780 |
Why?
|
| Papillomavirus Vaccines | 2 | 2020 | 93 | 0.770 |
Why?
|
| Data Collection | 7 | 2010 | 420 | 0.740 |
Why?
|
| Research Support as Topic | 2 | 2016 | 58 | 0.730 |
Why?
|
| Mentoring | 2 | 2022 | 53 | 0.710 |
Why?
|
| Trust | 4 | 2021 | 75 | 0.710 |
Why?
|
| Male | 53 | 2022 | 37321 | 0.700 |
Why?
|
| Papillomavirus Infections | 2 | 2020 | 194 | 0.690 |
Why?
|
| Patient Education as Topic | 4 | 2015 | 425 | 0.690 |
Why?
|
| Community Health Workers | 2 | 2019 | 32 | 0.690 |
Why?
|
| Mental Recall | 2 | 2012 | 72 | 0.680 |
Why?
|
| Communication | 4 | 2015 | 329 | 0.680 |
Why?
|
| Comprehension | 2 | 2012 | 71 | 0.680 |
Why?
|
| Attitude of Health Personnel | 5 | 2018 | 442 | 0.680 |
Why?
|
| Qualitative Research | 8 | 2016 | 369 | 0.680 |
Why?
|
| Students | 1 | 2021 | 233 | 0.670 |
Why?
|
| Vaccination | 2 | 2020 | 189 | 0.660 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2020 | 77 | 0.650 |
Why?
|
| Informed Consent | 2 | 2012 | 127 | 0.640 |
Why?
|
| Perception | 2 | 2012 | 189 | 0.640 |
Why?
|
| Research Design | 5 | 2017 | 729 | 0.630 |
Why?
|
| Colonoscopy | 1 | 2019 | 156 | 0.630 |
Why?
|
| Mammography | 2 | 2019 | 310 | 0.610 |
Why?
|
| Surveys and Questionnaires | 11 | 2019 | 2800 | 0.600 |
Why?
|
| Aged, 80 and over | 16 | 2019 | 4848 | 0.600 |
Why?
|
| Physician-Patient Relations | 3 | 2015 | 261 | 0.600 |
Why?
|
| Colonic Neoplasms | 2 | 2021 | 299 | 0.590 |
Why?
|
| United States | 24 | 2021 | 7367 | 0.590 |
Why?
|
| Psychometrics | 6 | 2016 | 514 | 0.580 |
Why?
|
| Research Subjects | 2 | 2018 | 45 | 0.570 |
Why?
|
| Body Mass Index | 2 | 2020 | 867 | 0.560 |
Why?
|
| Diabetes Complications | 1 | 2018 | 249 | 0.550 |
Why?
|
| Government Programs | 1 | 2016 | 16 | 0.550 |
Why?
|
| Community-Based Participatory Research | 2 | 2015 | 133 | 0.540 |
Why?
|
| Survivors | 2 | 2015 | 256 | 0.540 |
Why?
|
| Socioeconomic Factors | 9 | 2017 | 955 | 0.530 |
Why?
|
| Case Management | 2 | 2006 | 46 | 0.510 |
Why?
|
| Evaluation Studies as Topic | 1 | 2015 | 219 | 0.500 |
Why?
|
| Program Evaluation | 5 | 2013 | 502 | 0.470 |
Why?
|
| Decision Making | 5 | 2013 | 410 | 0.470 |
Why?
|
| Continuity of Patient Care | 1 | 2015 | 170 | 0.470 |
Why?
|
| Parkinson Disease | 3 | 2012 | 272 | 0.460 |
Why?
|
| Caregivers | 3 | 2014 | 365 | 0.460 |
Why?
|
| Terminal Care | 5 | 2015 | 92 | 0.440 |
Why?
|
| Motor Activity | 1 | 2016 | 621 | 0.440 |
Why?
|
| Focus Groups | 8 | 2018 | 247 | 0.430 |
Why?
|
| Ovarian Neoplasms | 4 | 2016 | 267 | 0.430 |
Why?
|
| Financing, Organized | 1 | 2012 | 21 | 0.410 |
Why?
|
| Urban Population | 4 | 2013 | 255 | 0.410 |
Why?
|
| Delivery of Health Care | 2 | 2015 | 445 | 0.390 |
Why?
|
| Health Behavior | 2 | 2006 | 458 | 0.390 |
Why?
|
| Sleep Apnea Syndromes | 2 | 2022 | 40 | 0.380 |
Why?
|
| Logistic Models | 7 | 2020 | 1420 | 0.370 |
Why?
|
| Quality of Life | 5 | 2014 | 1515 | 0.360 |
Why?
|
| Tonsillectomy | 2 | 2022 | 69 | 0.360 |
Why?
|
| Indians, North American | 1 | 2010 | 64 | 0.360 |
Why?
|
| Adult | 23 | 2019 | 21403 | 0.360 |
Why?
|
| Mentors | 4 | 2022 | 81 | 0.360 |
Why?
|
| Receptors, Estrogen | 3 | 2020 | 142 | 0.350 |
Why?
|
| Colorectal Surgery | 1 | 2009 | 11 | 0.340 |
Why?
|
| Quality of Health Care | 1 | 2012 | 322 | 0.340 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2012 | 931 | 0.330 |
Why?
|
| Evidence-Based Medicine | 1 | 2012 | 438 | 0.330 |
Why?
|
| Prognosis | 5 | 2020 | 2093 | 0.330 |
Why?
|
| Advance Care Planning | 4 | 2015 | 11 | 0.320 |
Why?
|
| Cooperative Behavior | 4 | 2016 | 235 | 0.320 |
Why?
|
| Registries | 5 | 2016 | 733 | 0.320 |
Why?
|
| Health Surveys | 3 | 2016 | 489 | 0.320 |
Why?
|
| Patient Dropouts | 2 | 2006 | 98 | 0.320 |
Why?
|
| Insurance, Health | 2 | 2020 | 201 | 0.310 |
Why?
|
| Social Work | 3 | 2006 | 27 | 0.300 |
Why?
|
| Health Promotion | 1 | 2012 | 407 | 0.300 |
Why?
|
| Pneumonectomy | 1 | 2008 | 79 | 0.300 |
Why?
|
| Depressive Disorder | 1 | 2012 | 621 | 0.300 |
Why?
|
| Papillomaviridae | 2 | 2020 | 104 | 0.300 |
Why?
|
| Reproducibility of Results | 3 | 2015 | 2077 | 0.290 |
Why?
|
| Risk Factors | 11 | 2020 | 5731 | 0.290 |
Why?
|
| Attitude to Death | 4 | 2013 | 52 | 0.290 |
Why?
|
| Culture | 4 | 2016 | 75 | 0.290 |
Why?
|
| Women | 1 | 2007 | 40 | 0.290 |
Why?
|
| Genetic Counseling | 1 | 2007 | 45 | 0.290 |
Why?
|
| Organizational Objectives | 3 | 2017 | 70 | 0.290 |
Why?
|
| Incidence | 5 | 2017 | 1603 | 0.290 |
Why?
|
| Alzheimer Disease | 2 | 2022 | 565 | 0.280 |
Why?
|
| Cross-Cultural Comparison | 4 | 2013 | 68 | 0.270 |
Why?
|
| Cultural Diversity | 3 | 2018 | 67 | 0.270 |
Why?
|
| Glycation End Products, Advanced | 2 | 2018 | 125 | 0.260 |
Why?
|
| Stroke | 1 | 2018 | 2163 | 0.260 |
Why?
|
| Telephone | 3 | 2016 | 160 | 0.250 |
Why?
|
| Smoking | 5 | 2020 | 1452 | 0.250 |
Why?
|
| Heart Failure | 1 | 2014 | 1180 | 0.250 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2008 | 300 | 0.250 |
Why?
|
| Veterans | 6 | 2015 | 904 | 0.240 |
Why?
|
| Diabetes Mellitus | 2 | 2002 | 694 | 0.240 |
Why?
|
| Educational Status | 4 | 2010 | 273 | 0.240 |
Why?
|
| Odds Ratio | 3 | 2020 | 880 | 0.240 |
Why?
|
| Mass Chest X-Ray | 1 | 2003 | 2 | 0.220 |
Why?
|
| Urban Health Services | 1 | 2002 | 24 | 0.210 |
Why?
|
| Asthma | 2 | 1997 | 345 | 0.210 |
Why?
|
| Health Care Coalitions | 1 | 2002 | 13 | 0.200 |
Why?
|
| Health Maintenance Organizations | 1 | 2002 | 22 | 0.200 |
Why?
|
| Social Class | 3 | 2020 | 127 | 0.200 |
Why?
|
| Cleft Palate | 1 | 2021 | 34 | 0.190 |
Why?
|
| Cleft Lip | 1 | 2021 | 33 | 0.190 |
Why?
|
| Research Personnel | 2 | 2021 | 83 | 0.190 |
Why?
|
| Faculty | 1 | 2021 | 56 | 0.190 |
Why?
|
| Sickness Impact Profile | 1 | 2001 | 27 | 0.190 |
Why?
|
| Michigan | 4 | 2003 | 68 | 0.190 |
Why?
|
| Nasal Surgical Procedures | 1 | 2020 | 21 | 0.180 |
Why?
|
| Respiratory System | 1 | 2020 | 28 | 0.180 |
Why?
|
| Geriatrics | 1 | 2000 | 69 | 0.170 |
Why?
|
| Foreign Bodies | 1 | 2020 | 58 | 0.170 |
Why?
|
| Racism | 1 | 2020 | 59 | 0.170 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 213 | 0.170 |
Why?
|
| Survival Rate | 3 | 2016 | 1056 | 0.160 |
Why?
|
| Cancer Care Facilities | 1 | 2019 | 32 | 0.160 |
Why?
|
| Radio | 1 | 2018 | 4 | 0.160 |
Why?
|
| Health Services Accessibility | 3 | 2020 | 581 | 0.160 |
Why?
|
| Health Communication | 1 | 2018 | 19 | 0.160 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2021 | 142 | 0.160 |
Why?
|
| United States Department of Veterans Affairs | 2 | 2014 | 307 | 0.160 |
Why?
|
| Paranasal Sinuses | 1 | 2020 | 165 | 0.160 |
Why?
|
| Postoperative Complications | 3 | 2021 | 1615 | 0.160 |
Why?
|
| Bronchoscopy | 1 | 2020 | 147 | 0.160 |
Why?
|
| Medically Underserved Area | 1 | 2018 | 85 | 0.160 |
Why?
|
| Comorbidity | 3 | 2020 | 1426 | 0.150 |
Why?
|
| Inservice Training | 1 | 2018 | 68 | 0.150 |
Why?
|
| Dementia | 2 | 2010 | 158 | 0.150 |
Why?
|
| Program Development | 2 | 2016 | 240 | 0.150 |
Why?
|
| Endoscopy | 1 | 2020 | 464 | 0.140 |
Why?
|
| Rural Health Services | 1 | 1998 | 101 | 0.140 |
Why?
|
| Age Factors | 5 | 2021 | 1864 | 0.140 |
Why?
|
| Spirituality | 2 | 2014 | 38 | 0.140 |
Why?
|
| Religion and Psychology | 1 | 2016 | 15 | 0.140 |
Why?
|
| Life Style | 1 | 2018 | 338 | 0.140 |
Why?
|
| Religion and Medicine | 1 | 1996 | 25 | 0.130 |
Why?
|
| Community-Institutional Relations | 2 | 2013 | 59 | 0.130 |
Why?
|
| Mental Health Services | 1 | 1998 | 199 | 0.130 |
Why?
|
| Social Values | 1 | 2015 | 34 | 0.130 |
Why?
|
| Young Adult | 5 | 2019 | 5717 | 0.130 |
Why?
|
| Minority Health | 2 | 2013 | 14 | 0.130 |
Why?
|
| Pilot Projects | 4 | 2021 | 1342 | 0.130 |
Why?
|
| Chi-Square Distribution | 2 | 2009 | 546 | 0.130 |
Why?
|
| Medically Uninsured | 2 | 2020 | 99 | 0.120 |
Why?
|
| Prospective Studies | 4 | 2021 | 3705 | 0.120 |
Why?
|
| Medicine | 1 | 2015 | 52 | 0.120 |
Why?
|
| Information Dissemination | 1 | 2015 | 113 | 0.120 |
Why?
|
| Prevalence | 2 | 2017 | 1619 | 0.120 |
Why?
|
| Office Visits | 1 | 2014 | 83 | 0.120 |
Why?
|
| Stroke Rehabilitation | 1 | 2018 | 335 | 0.120 |
Why?
|
| Child, Preschool | 4 | 2022 | 3187 | 0.110 |
Why?
|
| False Positive Reactions | 2 | 2005 | 95 | 0.110 |
Why?
|
| Hospitals, Veterans | 1 | 2014 | 147 | 0.110 |
Why?
|
| Adolescent | 7 | 2020 | 8912 | 0.110 |
Why?
|
| Retrospective Studies | 6 | 2022 | 7277 | 0.110 |
Why?
|
| Patient Satisfaction | 2 | 2014 | 378 | 0.110 |
Why?
|
| Personality | 1 | 2013 | 66 | 0.110 |
Why?
|
| Self Care | 1 | 1996 | 253 | 0.110 |
Why?
|
| Child | 5 | 2022 | 6405 | 0.110 |
Why?
|
| Analysis of Variance | 2 | 2008 | 1040 | 0.110 |
Why?
|
| Guideline Adherence | 1 | 2015 | 287 | 0.110 |
Why?
|
| Capacity Building | 1 | 2012 | 17 | 0.100 |
Why?
|
| Delayed Diagnosis | 1 | 2012 | 39 | 0.100 |
Why?
|
| Sex Factors | 3 | 2021 | 1266 | 0.100 |
Why?
|
| Referral and Consultation | 3 | 2020 | 383 | 0.100 |
Why?
|
| Neoplasm Staging | 2 | 2018 | 800 | 0.100 |
Why?
|
| Patient-Centered Care | 1 | 2013 | 106 | 0.100 |
Why?
|
| Physician's Role | 2 | 2009 | 116 | 0.100 |
Why?
|
| Hypertension | 3 | 2010 | 1535 | 0.100 |
Why?
|
| Follow-Up Studies | 2 | 2015 | 3259 | 0.100 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 1046 | 0.100 |
Why?
|
| Universities | 1 | 2012 | 191 | 0.100 |
Why?
|
| Southeastern United States | 1 | 2012 | 281 | 0.100 |
Why?
|
| Tobacco Use Cessation | 1 | 2011 | 44 | 0.100 |
Why?
|
| Factor Analysis, Statistical | 2 | 2002 | 201 | 0.090 |
Why?
|
| Schools, Medical | 1 | 2012 | 157 | 0.090 |
Why?
|
| Random Allocation | 1 | 2012 | 442 | 0.090 |
Why?
|
| Survival Analysis | 2 | 2013 | 714 | 0.090 |
Why?
|
| Biomarkers, Tumor | 1 | 2014 | 508 | 0.090 |
Why?
|
| Terminally Ill | 2 | 2008 | 17 | 0.090 |
Why?
|
| Social Environment | 1 | 2012 | 182 | 0.090 |
Why?
|
| Immunohistochemistry | 2 | 2014 | 1174 | 0.090 |
Why?
|
| Self-Assessment | 1 | 2010 | 69 | 0.090 |
Why?
|
| Time Factors | 1 | 2018 | 4655 | 0.090 |
Why?
|
| Poverty | 2 | 2012 | 219 | 0.090 |
Why?
|
| Smoking Prevention | 1 | 2011 | 259 | 0.090 |
Why?
|
| Poverty Areas | 1 | 2009 | 20 | 0.090 |
Why?
|
| Health Personnel | 1 | 2012 | 286 | 0.090 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 2279 | 0.090 |
Why?
|
| Reoperation | 2 | 2021 | 467 | 0.080 |
Why?
|
| Adaptation, Psychological | 1 | 2013 | 447 | 0.080 |
Why?
|
| Self Efficacy | 1 | 2010 | 199 | 0.080 |
Why?
|
| Professional Role | 1 | 2009 | 80 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 1998 | 1085 | 0.080 |
Why?
|
| Antihypertensive Agents | 2 | 2010 | 498 | 0.080 |
Why?
|
| Income | 1 | 2009 | 167 | 0.080 |
Why?
|
| Interviews as Topic | 2 | 2012 | 392 | 0.080 |
Why?
|
| Educational Measurement | 1 | 2010 | 254 | 0.080 |
Why?
|
| Consent Forms | 1 | 2008 | 4 | 0.080 |
Why?
|
| Confidence Intervals | 1 | 2008 | 242 | 0.080 |
Why?
|
| Medicaid | 2 | 2020 | 302 | 0.080 |
Why?
|
| Probability | 1 | 2008 | 245 | 0.080 |
Why?
|
| Double-Blind Method | 1 | 2012 | 1738 | 0.080 |
Why?
|
| Forecasting | 1 | 2008 | 277 | 0.070 |
Why?
|
| Community Participation | 1 | 2007 | 42 | 0.070 |
Why?
|
| Geriatric Assessment | 1 | 2007 | 107 | 0.070 |
Why?
|
| Fear | 1 | 2007 | 239 | 0.070 |
Why?
|
| Censuses | 1 | 2005 | 6 | 0.070 |
Why?
|
| Health Services for the Aged | 1 | 2005 | 21 | 0.070 |
Why?
|
| Acculturation | 1 | 2005 | 25 | 0.060 |
Why?
|
| Activities of Daily Living | 2 | 2013 | 319 | 0.060 |
Why?
|
| Medication Adherence | 1 | 2009 | 335 | 0.060 |
Why?
|
| Preventive Health Services | 1 | 2006 | 86 | 0.060 |
Why?
|
| Intention | 1 | 2006 | 80 | 0.060 |
Why?
|
| Risk Assessment | 2 | 2008 | 2007 | 0.060 |
Why?
|
| Cohort Studies | 4 | 2013 | 2358 | 0.060 |
Why?
|
| Academic Medical Centers | 1 | 2007 | 281 | 0.060 |
Why?
|
| Rural Population | 1 | 2008 | 398 | 0.060 |
Why?
|
| Neuropsychological Tests | 1 | 2007 | 517 | 0.060 |
Why?
|
| Infant | 2 | 2021 | 2891 | 0.060 |
Why?
|
| Anxiety | 1 | 2007 | 422 | 0.060 |
Why?
|
| Prostate-Specific Antigen | 1 | 2005 | 138 | 0.060 |
Why?
|
| Sex Distribution | 2 | 2009 | 274 | 0.060 |
Why?
|
| Blood Pressure | 1 | 2010 | 1451 | 0.060 |
Why?
|
| Age Distribution | 2 | 2009 | 320 | 0.060 |
Why?
|
| Midwestern United States | 1 | 2002 | 36 | 0.050 |
Why?
|
| Databases, Factual | 2 | 2020 | 622 | 0.050 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2017 | 109 | 0.050 |
Why?
|
| Epidemiologic Methods | 1 | 2002 | 83 | 0.050 |
Why?
|
| Polysomnography | 1 | 2022 | 92 | 0.050 |
Why?
|
| Genes, MHC Class I | 1 | 2021 | 14 | 0.050 |
Why?
|
| Genes, MHC Class II | 1 | 2021 | 29 | 0.050 |
Why?
|
| Advance Directives | 2 | 2013 | 22 | 0.050 |
Why?
|
| Immunophenotyping | 1 | 2021 | 110 | 0.050 |
Why?
|
| Terminology as Topic | 1 | 2002 | 141 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2002 | 1753 | 0.050 |
Why?
|
| Disease Management | 1 | 2002 | 248 | 0.050 |
Why?
|
| Adenoidectomy | 1 | 2021 | 51 | 0.050 |
Why?
|
| Marketing of Health Services | 1 | 2020 | 18 | 0.050 |
Why?
|
| Aging | 1 | 2007 | 911 | 0.050 |
Why?
|
| Immunity, Cellular | 1 | 2021 | 80 | 0.050 |
Why?
|
| Immunity | 1 | 2021 | 67 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 2 | 2017 | 186 | 0.050 |
Why?
|
| Eligibility Determination | 1 | 2020 | 31 | 0.050 |
Why?
|
| Societies | 1 | 2000 | 15 | 0.050 |
Why?
|
| Elective Surgical Procedures | 1 | 2020 | 95 | 0.040 |
Why?
|
| Proportional Hazards Models | 2 | 2013 | 792 | 0.040 |
Why?
|
| Linear Models | 1 | 2021 | 521 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2021 | 329 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 266 | 0.040 |
Why?
|
| Interprofessional Relations | 1 | 2000 | 188 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2018 | 111 | 0.040 |
Why?
|
| Tamoxifen | 1 | 2018 | 62 | 0.040 |
Why?
|
| Ohio | 1 | 1998 | 64 | 0.040 |
Why?
|
| Gene Expression | 1 | 2021 | 770 | 0.040 |
Why?
|
| Stakeholder Participation | 1 | 2018 | 17 | 0.040 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 99 | 0.040 |
Why?
|
| Allied Health Personnel | 1 | 1998 | 37 | 0.040 |
Why?
|
| Phenotype | 1 | 2021 | 947 | 0.040 |
Why?
|
| Absenteeism | 1 | 1997 | 27 | 0.040 |
Why?
|
| Health Care Costs | 1 | 2020 | 346 | 0.040 |
Why?
|
| Macrophages | 1 | 2021 | 647 | 0.040 |
Why?
|
| Interpersonal Relations | 1 | 2018 | 209 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2018 | 332 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2018 | 7029 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 951 | 0.030 |
Why?
|
| SEER Program | 1 | 2016 | 153 | 0.030 |
Why?
|
| Texas | 1 | 2015 | 92 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 772 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2010 | 504 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 1998 | 1054 | 0.030 |
Why?
|
| Hospitalization | 1 | 2020 | 978 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 282 | 0.030 |
Why?
|
| Personal Autonomy | 1 | 2013 | 22 | 0.030 |
Why?
|
| Altruism | 1 | 2013 | 24 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 1851 | 0.030 |
Why?
|
| Biomarkers | 1 | 2018 | 1593 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 507 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2017 | 413 | 0.030 |
Why?
|
| Uncertainty | 1 | 2013 | 31 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2016 | 1553 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 536 | 0.030 |
Why?
|
| Sample Size | 1 | 2012 | 79 | 0.030 |
Why?
|
| Curriculum | 1 | 1996 | 575 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2013 | 306 | 0.020 |
Why?
|
| Smoking Cessation | 1 | 2020 | 1034 | 0.020 |
Why?
|
| Self Report | 1 | 2013 | 371 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 1997 | 711 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2013 | 252 | 0.020 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 1 | 2010 | 8 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 2010 | 138 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2018 | 2689 | 0.020 |
Why?
|
| Memantine | 1 | 2009 | 10 | 0.020 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2009 | 58 | 0.020 |
Why?
|
| Drug Utilization | 1 | 2009 | 119 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2010 | 782 | 0.020 |
Why?
|
| Health Planning | 1 | 2007 | 23 | 0.020 |
Why?
|
| Organizational Case Studies | 1 | 2007 | 53 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2007 | 186 | 0.020 |
Why?
|
| Bias | 1 | 2005 | 148 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2007 | 294 | 0.010 |
Why?
|
| Palliative Care | 1 | 2007 | 271 | 0.010 |
Why?
|
| Postal Service | 1 | 2002 | 19 | 0.010 |
Why?
|
| Motivation | 1 | 2002 | 561 | 0.010 |
Why?
|